Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, or CAR-T cell therapy. Over time, the engineered immune ...

A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...

Mayo Clinic researchers say they have identified why some cancer patients relapse after receiving CAR-T cell therapy. The ...

Once injected back into the patient, the CAR-T cells tend to rapidly expand when they become activated by the tumor cells, but eventually die off due to a natural process called activation-induced ...

In addition, huCART19-IL18 is manufactured in a rapid, 3-day process that is designed to preserve stem-cell–like characteristics and reduce exhaustion in T cells. 24,25 To mitigate ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, June 09). COVID boosters do not harm T-cell function in the vulnerable.